The Shanghai Jiao Tong University School of Medicine, formerly Shanghai Second Medical University, is a public medical school in Shanghai, China. Clinical medicine of SJTUSM is consistently ranked first among medical schools nationally and #84 by the U.S. News & World Report globally.

During the past decade, Renji Hospital Department of Endocrinology and Metabolism conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Renji Hospital Department of Endocrinology and Metabolism" #1 collaborator was "Unity Health Toronto" with 1 trials as a collaborator, "University of Florida" with 1 trials as a collaborator and "University of Massachusetts, Worcester" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Renji Hospital Department of Endocrinology and Metabolism" are "Polycystic Ovary Syndrome" (3 trials), "Autoimmune Diseases" (1 trials), "Diabetes Mellitus" (1 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Endocrine System Diseases" (1 trials). Many other conditions were trialed in "Renji Hospital Department of Endocrinology and Metabolism" in a lesser frequency.

Most popular intervention types in "Renji Hospital Department of Endocrinology and Metabolism" are "Drug" (5 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Metformin" (3 trials), "Acarbose" (1 trials), "Acarbose 100 MG" (1 trials), "Exenatide" (1 trials) and "GLP-1 Receptor Agonists" (1 trials). Other intervention names were less common.

The vast majority of trials in "Renji Hospital Department of Endocrinology and Metabolism" are 4 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Renji Hospital Department of Endocrinology and Metabolism". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Renji Hospital Department of Endocrinology and Metabolism, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Renji Hospital Department of Endocrinology and Metabolism, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".